Shaman Pharmaceuticals Report issue

Contributed to NME For profit Phase 3
Founded: South San Francisco CA United States (1989)
Status: Defunct (2005)

Organization Overview

First Clinical Trial
1999
NCT00002186
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Alternative names

Shamen Pharmaceuticals

Active Ingredients

Drugs in Phase 3 Trials (1)

crofelemer (mytesi) (3 trials)

Drugs in Other Trials (1)

aciclovir (zovirax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 3)

Diarrhea (Phase 3)

HIV Infections (Phase 3)

Immunologic Deficiency Syndromes (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2